We have a drug that could transform HIV prevention. So why can’t millions get it?
A twice-yearly injection could revolutionise HIV prevention. But who gets access raises bigger questions about public money, pharmaceutical power, drug prices and shrinking global health funding. Al Jazeera’s Mikail Malik looks at the fight over access.
Originally reported by Al Jazeera. Read the full story at the original source.
xwhatsapp-strokecopylinkgoogleAdd Al Jazeera on GoogleinfoPolice officers patrol outside the West Kowloon Law Courts Bui...
A Russian attack drone crashed into a children’s playground in Kyiv, Ukraine without exploding.
To play this video you need to enable JavaScript in your browser.This video can not be playedFigure caption, Watch: Mome...
Follow the day’s news live.Get our breaking news email, free app or daily news podcastShoebridge says people are sick of...